GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DT&CRO Co Ltd (XKRX:383930) » Definitions » Common Stock

DT&CRO Co (XKRX:383930) Common Stock : ₩6,385 Mil (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is DT&CRO Co Common Stock?

DT&CRO Co's quarterly common stock stayed the same from Dec. 2023 (₩6,365 Mil) to Mar. 2024 (₩6,365 Mil) but then increased from Mar. 2024 (₩6,365 Mil) to Jun. 2024 (₩6,385 Mil).

DT&CRO Co's annual common stock increased from Dec. 2021 (₩2,437 Mil) to Dec. 2022 (₩3,158 Mil) and increased from Dec. 2022 (₩3,158 Mil) to Dec. 2023 (₩6,365 Mil).


DT&CRO Co Common Stock Historical Data

The historical data trend for DT&CRO Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DT&CRO Co Common Stock Chart

DT&CRO Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Common Stock
1,605.00 2,436.63 3,157.63 6,365.26

DT&CRO Co Quarterly Data
Jun21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 6,347.26 6,347.26 6,365.26 6,365.26 6,385.26

DT&CRO Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


DT&CRO Co Business Description

Traded in Other Exchanges
N/A
Address
28, Baengnyeong-ro 20beon-gil, 2nd, 3rd, 4th floor, Na-dong, Cheoin-gu, Gyeonggi-do (Yubang-dong), Yongin-si, KOR, 17042
DT&CRO Co Ltd conducts a series of consigned research, from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional foods, cosmetics and medical devices, to analysis, bioactivity, clinical trials, and licensing consulting. provided as a service.

DT&CRO Co Headlines

No Headlines